These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24423358)

  • 1. The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition.
    Samuels MH; Kolobova I; Smeraglio A; Peters D; Janowsky JS; Schuff KG
    J Clin Endocrinol Metab; 2014 Mar; 99(3):843-51. PubMed ID: 24423358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health status, psychological symptoms, mood, and cognition in L-thyroxine-treated hypothyroid subjects.
    Samuels MH; Schuff KG; Carlson NE; Carello P; Janowsky JS
    Thyroid; 2007 Mar; 17(3):249-58. PubMed ID: 17381359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Altering Levothyroxine (L-T4) Doses on Quality of Life, Mood, and Cognition in L-T4 Treated Subjects.
    Samuels MH; Kolobova I; Niederhausen M; Janowsky JS; Schuff KG
    J Clin Endocrinol Metab; 2018 May; 103(5):1997-2008. PubMed ID: 29509918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health status, mood, and cognition in experimentally induced subclinical hypothyroidism.
    Samuels MH; Schuff KG; Carlson NE; Carello P; Janowsky JS
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2545-51. PubMed ID: 17473069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Thyroid Function Variations Within the Laboratory Reference Range on Health Status, Mood, and Cognition in Levothyroxine-Treated Subjects.
    Samuels MH; Kolobova I; Smeraglio A; Niederhausen M; Janowsky JS; Schuff KG
    Thyroid; 2016 Sep; 26(9):1173-84. PubMed ID: 27338133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health status, mood, and cognition in experimentally induced subclinical thyrotoxicosis.
    Samuels MH; Schuff KG; Carlson NE; Carello P; Janowsky JS
    J Clin Endocrinol Metab; 2008 May; 93(5):1730-6. PubMed ID: 18285414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Levothyroxine Replacement or Suppressive Therapy on Energy Expenditure and Body Composition.
    Samuels MH; Kolobova I; Smeraglio A; Peters D; Purnell JQ; Schuff KG
    Thyroid; 2016 Mar; 26(3):347-55. PubMed ID: 26700485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of long-term thyroid-stimulating hormone suppressive therapy on the cognitive function of elderly patients with differentiated thyroid carcinoma.
    Moon JH; Ahn S; Seo J; Han JW; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Kim KW; Jang HC
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3782-9. PubMed ID: 25029415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive doses of thyroxine do not accelerate age-related bone loss in late postmenopausal women.
    Fujiyama K; Kiriyama T; Ito M; Kimura H; Ashizawa K; Tsuruta M; Nagayama Y; Villadolid MC; Yokoyama N; Nagataki S
    Thyroid; 1995 Feb; 5(1):13-7. PubMed ID: 7787427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary nodular disease and multinodular goiter: a retrospective study on suppressive versus replacement levothyroxine therapy.
    Paggi A; Persegani-Trimarchi C; Russo P; Mastropasqua M; Mosetti MA; Losi T; Leri O
    Endocr Res; 1999 May; 25(2):229-38. PubMed ID: 10382684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
    Ongphiphadhanakul B; Puavilai G; Rajatanavin R
    J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study.
    Jin S; Yang YT; Bao W; Bai Y; Ai JW; Liu Y; Yong H
    Endocrine; 2019 Aug; 65(2):327-337. PubMed ID: 31056722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring.
    Mercuro G; Panzuto MG; Bina A; Leo M; Cabula R; Petrini L; Pigliaru F; Mariotti S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):159-64. PubMed ID: 10634380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients.
    Lombardi CP; Bocale R; Barini A; Barini A; D'Amore A; Boscherini M; Bellantone R
    Endocrine; 2017 Jan; 55(1):51-59. PubMed ID: 27388589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroxine replacement therapy and circulating lipid concentrations.
    Franklyn JA; Daykin J; Betteridge J; Hughes EA; Holder R; Jones SR; Sheppard MC
    Clin Endocrinol (Oxf); 1993 May; 38(5):453-9. PubMed ID: 8330440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects.
    Huang F; Ajavon A; Huang E; Lettieri J; Liu R; Peña C; Berse M
    Thyroid; 2017 Sep; 27(9):1118-1127. PubMed ID: 28741453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study.
    Parle J; Roberts L; Wilson S; Pattison H; Roalfe A; Haque MS; Heath C; Sheppard M; Franklyn J; Hobbs FD
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3623-32. PubMed ID: 20501682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The associations of polymorphisms of TSH receptor and thyroid hormone receptor genes with L-thyroxine treatment in hypothyroid patients.
    Al-Azzam SI; Alzoubi KH; Khabour O; Al-Azzeh O
    Hormones (Athens); 2014; 13(3):389-97. PubMed ID: 25079464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.